πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9458141

Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458086

Compositions and methods for adipocyte modulation

The United States of America as Represented by the Department of Veterans Affairs Office of General Counselβ€”PSG IV (024) Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457132

Controlled covalent attachment of bioactive bacteriophage for regulating biofilm developme

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458215

Compositions and methods for osteogenic gene therapy

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453239

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag a

The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453019

Linked purine pterin HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9452973

Modulators of the relaxin receptor 1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9447144

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446048

Methods for treating leukemia and disorders mediated by CBFΞ² and RUNX1 proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441050

High-affinity monoclonal anti-prion antibodies

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441048

Antibody for 3β€²-isoLM1 and 3β€²,6β€²-iso-LD1 gangliosides

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441041

Use of antagonists of the interaction between HIV GP120 and Ξ±4Ξ²7 integrin

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441022

Aegyptin and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441019

Influenza hemagglutinin protein-based vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439979

Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439978

Multilayered magnetic micelle compositions and methods for their use

The United States of America as represented by National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), U.S. Government Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439935

Recombinant rift valley fever (RVF) viruses and methods

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439875

Anxiolytic effect of pterostilbene

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9435000

Primate T-lymphotropic viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9428541

Substrate reduction therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9427476

Multivalent meningococcal conjugates and methods for preparing conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421254

Immunostimulatory combinations of TLR ligands and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421250

Pathogenic phlebovirus isolates and compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9416190

Mesothelin antibodies and methods for eliciting potent antitumor activity

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted